يعرض 21 - 40 نتائج من 16,878 نتيجة بحث عن '(( 50 ns decrease ) OR ((( 50 ((mean decrease) OR (a decrease)) ) OR ( 50 we decrease ))))', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25

    Flow chart of the study procedures. حسب Kazuhiko Ikeuchi (9234268)

    منشور في 2023
    "…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…"
  6. 26
  7. 27
  8. 28
  9. 29

    Exposure to low CO<sub>2</sub> levels decreases ER cholesterol levels. حسب Nityanand Bolshette (17396845)

    منشور في 2023
    "…<b>(F)</b> qPCR analysis for cholesterogenic genes from NIH3T3 cells exposed to cholesterol (50 μm) or 25-hydroxycholesterol (10 μm) under 5% or 1% CO<sub>2</sub> for 4 h (mean ± SE, <i>n</i> = 3 biological replicates per condition, ***<i>P</i> < 0.001, nonsignificant (ns), two-way ANOVA with Bonferroni’s multiple comparisons test). …"
  10. 30
  11. 31

    Datasheet1_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf حسب Benjamin Morat (17677977)

    منشور في 2023
    "…No significant difference was observed between medians of HbA1c_mean and HbA1c_after values (8.37% [7.88; 9.32%] vs. 8.50% [7.70; 9.50%], respectively; p = 0.391). …"
  12. 32

    Datasheet2_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf حسب Benjamin Morat (17677977)

    منشور في 2023
    "…No significant difference was observed between medians of HbA1c_mean and HbA1c_after values (8.37% [7.88; 9.32%] vs. 8.50% [7.70; 9.50%], respectively; p = 0.391). …"
  13. 33
  14. 34
  15. 35
  16. 36
  17. 37
  18. 38

    Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant حسب Ittipat Meewan (7455041)

    منشور في 2019
    "…Several drugs targeting the protease have been developed, but drug-resistant mutant strains emerged. Here, we screened a library and synthesized a novel class of small molecules based on a tryptophan derivative scaffold identified as HCV NS3/4A protease inhibitors that are active against both wild type and mutant form of the protease. …"
  19. 39
  20. 40